FDA Rejects Bid To Authorize Cheap Antidepressant As Covid Treatment Fluvoxamine has been used to treat depression and obsessive-compulsive disorder for 15 years, but its usefulness as a Covid-19 treatment has yet to be proven, the Food and Drug Administration said.